Procaps
Yahoo Finance • 2 years ago
Procaps Announces Key Changes to the Board of Directors
MIAMI and BARRANQUILLA, Colombia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced the election of Alberto Eguig... Full story
Yahoo Finance • 2 years ago
10 Cheap Pot Stocks to Buy
In this article, we will take a look at the 10 cheap pot stocks to buy. If you want to explore similar stocks, you can also take a look at 5 Cheap Pot Stocks To Buy. The pot industry includes the production, distribution, sale, and consum... Full story
Yahoo Finance • 2 years ago
Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar
MIAMI and BARRANQUILLA, Colombia, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the termination... Full story
Yahoo Finance • 2 years ago
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference
MIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced that it will pres... Full story
Yahoo Finance • 2 years ago
Update on Proposed Acquisition of Grupo Somar
MIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announces an update on its previousl... Full story
Yahoo Finance • 2 years ago
Procaps Group Reports Third Quarter and Nine Months 2022 Results
MIAMI and BARRANQUILLA, Colombia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its financial results for the three... Full story
Yahoo Finance • 2 years ago
Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022
MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it expects to report its results for the... Full story
Yahoo Finance • 2 years ago
Procaps Announces ESG Commitments and Initiatives with Inaugural Report
MIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the completion of its inaugural 2021 ESG... Full story
Yahoo Finance • 2 years ago
Procaps Group Reports Second Quarter and First Half 2022 Results
Net Revenues Increased 14% year-over-year in the Second Quarter, with Adjusted EBITDA Margin of 24% Constant currency Net Revenues Increased by 18% year-over-year in the First Half, signaling a strong demand across our businesses MIAMI an... Full story
Yahoo Finance • 2 years ago
Procaps Group Reports Preliminary First Quarter 2022 Results
MIAMI and BARRANQUILLA, Colombia, June 02, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its preliminary financial results f... Full story
Yahoo Finance • 3 years ago
Grupo Procaps adquire o Grupo Somar (incluindo Química y Farmacia, Gelcaps e entidades relacionadas) da Advent International, conquistando importante presença no México, segundo maior mercado da região
Esta aquisição reafirma a estratégia do Grupo Procaps de se tornar uma das organizações farmacêuticas que mais crescem na América Latina Com receita líquida de US$ 184 milhões no ano fiscal de 2021, o Grupo Somar é uma das empresas farmac... Full story
Yahoo Finance • 3 years ago
Grupo Procaps adquirirá Grupo Somar (incluyendo Química y Farmacia, Gelcaps y entidades relacionadas) de Advent International, ganando una importante presencia en México, el segundo mercado más grande de la región
Esta adquisición reafirma la estrategia de Procaps Group de convertirse en una de las organizaciones farmacéuticas de más rápido crecimiento en América Latina. Con ingresos netos de $184 millones en el año fiscal 2021, Grupo Somar es un... Full story
Yahoo Finance • 3 years ago
Procaps Group to Acquire Grupo Somar (including Química y Farmacia, Gelcaps and related entities) from Advent International, gaining an important presence in Mexico, the Region's Second Largest Market
This acquisition reaffirms Procaps Groups’ strategy to become one of the fastest growing pharmaceutical organizations in Latin America With FY2021 Net Revenues of $184 million, Grupo Somar is one of the most relevant independent pharma co... Full story
